These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32967112)

  • 1. Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients.
    Montaño A; Hernández-Sánchez J; Forero-Castro M; Matorra-Miguel M; Lumbreras E; Miguel C; Santos S; Ramírez-Maldonado V; Fuster JL; de Las Heras N; García-de Coca A; Sierra M; Dávila J; de la Fuente I; Olivier C; Olazabal J; Martínez J; Vega-García N; González T; Hernández-Rivas JM; Benito R
    J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32967112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia.
    Gil JV; Such E; Sargas C; Simarro J; Miralles A; Pérez G; de Juan I; Palanca S; Avetisyan G; Santiago M; Fuentes C; Fernández JM; Vicente AI; Romero S; Llop M; Barragán E
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology.
    Gargallo P; Molero M; Bilbao C; Stuckey R; Carrillo-Cruz E; Hermosín L; Pérez-López O; Jiménez-Velasco A; Soria E; Lázaro M; Carbonell P; Yáñez Y; Gómez I; Izquierdo-García M; Valero-García J; Ruiz C; Such E; Calabria I
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Molecular Investigations in Lysosomal Diseases: Clinical Integration of a Comprehensive Targeted Panel.
    Sudrié-Arnaud B; Snanoudj S; Dabaj I; Dranguet H; Abily-Donval L; Lebas A; Vezain M; Héron B; Marie I; Duval-Arnould M; Marret S; Tebani A; Bekri S
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33673364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations.
    Chicano M; Carbonell D; Suárez-González J; Lois S; Ballesteros-Culebras M; Andrés-Zayas C; Muñiz P; Rodríguez-Macias G; Bastos-Oreiro M; Font P; Ballesteros M; Kwon M; Anguita J; Díez-Martín JL; Buño I; Martínez-Laperche C
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of targeted NGS panel with comprehensive bioinformatics analysis for patients with acute lymphoblastic leukemia.
    Kim B; Lee H; Kim E; Shin S; Lee ST; Choi JR
    Leuk Lymphoma; 2019 Dec; 60(13):3138-3145. PubMed ID: 31203682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Next-Generation Sequencing Panel for Syndromic and Nonsyndromic Hearing Loss.
    Butz M; McDonald A; Lundquist PA; Meyer M; Harrington S; Kester S; Stein MI; Mistry NA; Zimmerman Zuckerman E; Niu Z; Schimmenti L; Hasadsri L; Boczek NJ
    J Appl Lab Med; 2020 May; 5(3):467-479. PubMed ID: 32445360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted resequencing of 9p in acute lymphoblastic leukemia yields concordant results with array CGH and reveals novel genomic alterations.
    Sarhadi VK; Lahti L; Scheinin I; Tyybäkinoja A; Savola S; Usvasalo A; Räty R; Elonen E; Ellonen P; Saarinen-Pihkala UM; Knuutila S
    Genomics; 2013 Sep; 102(3):182-8. PubMed ID: 23333812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.
    Su D; Zhang D; Chen K; Lu J; Wu J; Cao X; Ying L; Jin Q; Ye Y; Xie Z; Xiong L; Mao W; Li F
    J Exp Clin Cancer Res; 2017 Sep; 36(1):121. PubMed ID: 28882180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
    Navrkalova V; Plevova K; Hynst J; Pal K; Mareckova A; Reigl T; Jelinkova H; Vrzalova Z; Stranska K; Pavlova S; Panovska A; Janikova A; Doubek M; Kotaskova J; Pospisilova S
    J Mol Diagn; 2021 Aug; 23(8):959-974. PubMed ID: 34082072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
    Cheng DT; Prasad M; Chekaluk Y; Benayed R; Sadowska J; Zehir A; Syed A; Wang YE; Somar J; Li Y; Yelskaya Z; Wong D; Robson ME; Offit K; Berger MF; Nafa K; Ladanyi M; Zhang L
    BMC Med Genomics; 2017 May; 10(1):33. PubMed ID: 28526081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Calling Performance of a Rare Disease NGS Panel for Single Nucleotide and Copy Number Variants.
    Cacheiro P; Ordóñez-Ugalde A; Quintáns B; Piñeiro-Hermida S; Amigo J; García-Murias M; Pascual-Pascual SI; Grandas F; Arpa J; Carracedo A; Sobrido MJ
    Mol Diagn Ther; 2017 Jun; 21(3):303-313. PubMed ID: 28290094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer-Related Single-Nucleotide Variants and Copy Number Variants Using Simulated Cell-Free DNA.
    Yang X; Chu Y; Zhang R; Han Y; Zhang L; Fu Y; Li D; Peng R; Li D; Ding J; Li Z; Zhao M; Zhang K; Lu T; Yi L; Wu Q; Lin G; Xie J; Liu T; Yang L; Yi X; Li J
    J Mol Diagn; 2017 Jul; 19(4):525-536. PubMed ID: 28502728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive genetic testing for female and male infertility using next-generation sequencing.
    Patel B; Parets S; Akana M; Kellogg G; Jansen M; Chang C; Cai Y; Fox R; Niknazar M; Shraga R; Hunter C; Pollock A; Wisotzkey R; Jaremko M; Bisignano A; Puig O
    J Assist Reprod Genet; 2018 Aug; 35(8):1489-1496. PubMed ID: 29779145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of extranodal marginal zone lymphoma using next generation sequencing.
    Huh SJ; Oh SY; Lee S; Lee JH; Kim SH; Pak MK; Kim HJ
    Oncol Lett; 2020 Nov; 20(5):205. PubMed ID: 32963611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel.
    Aoe M; Ishida H; Matsubara T; Karakawa S; Kawaguchi H; Fujiwara K; Kanamitsu K; Washio K; Okada K; Shibakura M; Shimada A
    Int J Lab Hematol; 2018 Aug; 40(4):427-436. PubMed ID: 29575541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
    Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
    Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing.
    Ishida H; Iguchi A; Aoe M; Takahashi T; Tamefusa K; Kanamitsu K; Fujiwara K; Washio K; Matsubara T; Tsukahara H; Sanada M; Shimada A
    Ann Hematol; 2019 Mar; 98(3):657-668. PubMed ID: 30446805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Analytical Validation of a Targeted Next-Generation Sequencing Panel to Detect Actionable Mutations for Targeted Therapy.
    Wang D; Ma K; Deng W; Li J; Xiang S; Zhang Y; Fu Y; Dai H; Huang B
    Onco Targets Ther; 2021; 14():2423-2431. PubMed ID: 33854338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of BRCA1/2 large genomic rearrangement including BRCA1 promoter-region deletions using next-generation sequencing.
    Han E; Yoo J; Chae H; Lee S; Kim DH; Kim KJ; Kim Y; Kim M
    Clin Chim Acta; 2020 Jun; 505():49-54. PubMed ID: 32092317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.